Sensus Healthcare, Inc
SRTS
SRTS: Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating skin cancers including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
moreShow SRTS Financials
Recent trades of SRTS by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by SRTS's directors and management
Government lobbying spending instances
-
$20,000 Oct 13, 2020 Issue: Health Issues Medicare/Medicaid
-
$60,000 Jul 20, 2020 Issue: Health Issues Medicare/Medicaid
-
$20,000 Jan 06, 2020 Issue: Medicare/Medicaid Health Issues
-
$60,000 Oct 18, 2019 Issue: Medicare/Medicaid Health Issues
-
$60,000 Jul 17, 2019 Issue: Health Issues Medicare/Medicaid
-
$60,000 Apr 18, 2019 Issue: Health Issues Medicare/Medicaid
-
$20,000 Oct 15, 2014 Issue: Medicare/Medicaid
-
$20,000 Jan 07, 2014 Issue: Health Issues Manufacturing Taxation/Internal Revenue Code Medicare/Medicaid Medical/Disease Research/Clinical Labs
New patents grants
Federal grants, loans, and purchases
Followers on SRTS's company Twitter account
Number of mentions of SRTS in WallStreetBets Daily Discussion
Recent insights relating to SRTS
Recent picks made for SRTS stock on CNBC
ETFs with the largest estimated holdings in SRTS
Flights by private jets registered to SRTS